Effect of semaglutide versus placebo on cardiovascular outcomes by baseline HbA1c: SUSTAIN 6 and PIONEER 6 post hoc analysis

Hyo Jin Lim; Linda Mellbin; Deepak L Bhatt; Jens-peter David; Mark C Petrie; Søren Rasmussen; Philip Andreas Schytz; Tina Vilsbøll

대한당뇨병학회 International Congress of Diabetes and Metabolism Effect of semaglutide versus placebo on cardiovascular outcomes by baseline HbA1c: SUSTAIN 6 and PIONEER 6 post hoc analysis

( Hyo Jin Lim ) , ( Linda Mellbin ) , ( Deepak L Bhatt ) , ( Jens-peter David ) , ( Mark C Petrie ) , ( Søren Rasmussen ) , ( Philip Andreas Schytz ) , ( Tina Vilsbøll )

대한당뇨병학회 2022.10

International Congress of Diabetes and Metabolism vol. 2022 58-58(1pages)

More

Cite Copy URL Bookshelf

This article is 4 pages or less.

* This article cannot be purchased.

Abstract

Keywords

Table of Contents

References (0)

[자료제공 : 네이버학술정보]